PROCEPT BioRobotics (PRCT) Misses Q4 EPS by 21c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
TD Cowen on Procept BioRobotics Corp (PRCT): 'We are constructive after the big stock decline'
February 26, 2026 3:05 PM ESTTD Cowen analyst Joshua Jennings reiterated a Buy rating and $34.00 price target on Procept BioRobotics Corp (NASDAQ: PRCT).
The analyst comments "We are constructive after the big stock decline that followed the Q4 report. PRCT again made a strong case to justify its recent... More
